Article Figures & Data
Tables
Variables Patients with advanced AVB Age (years), median (IQR) 72 (58-79) Young patients (≤60-year-old) 29 (29.0) Male gender 51 (51.0) Hypertension 81 (81.0) Diabetes mellitus 76 (76.0) Dyslipidemia 35 (35.0) Any comorbidity (hypertension, diabetes mellitus, or dyslipidemia) 88 (88.0) Diagnosis CHB 67 (67.0) 2nd degree AVB 22 (22.0) AF with slow ventricular response 7 (7.0) Unknown 4 (4.0) Cause of AVB (idiopathic) 79 (79.0) Investigated for cardiac sarcoidosis 5 (5.0) Type of pacemaker (single) 44 (44.0) New-onset heart failure at one year 5/89 (9.1) Death at one year 7/89 (4.5) Values are presented as numbers and percentages (%).
IQR: interquartile range, CHB: complete heart block, AVB: atrioventricular block, AF: atrial fibrillation
- Table 2
- Characteristics of patients with atrioventricular block (idiopathic versus secondary).
Variables Idiopathic AVB (n=79) Secondary AVB (n=21) P-values Age (years), median (IQR) 72 (59-78) 72 (56-82) 0.969 Young patients (≤60 year-old) 21 (26.6) 8 (38.1) 0.301 Male gender 37 (46.8) 14 (66.7) 0.106 Hypertension 66 (83.5) 15 (71.4) 0.208 Diabetes mellitus 61 (76.9) 15 (71.4) 0.602 Dyslipidemia 29 (36.7) 6 (28.6) 0.487 Any comorbidity (hypertension, diabetes mellitus, or dyslipidemia) 73 (92.3) 15 (71.4) 0.009 Diagnosis CHB 52 (65.8) 15 (71.4) 0.389 2nd degree AVB 19 (24.1) 3 (14.3) AF with slow ventricular response 6 (7.6) 14 (4.8) Unknown 2 (2.5) 6 (9.5) Investigated for cardiac sarcoidosis 5 (6.3) -- -- Cause of AVB Post TAVI NA 4 (19.1) -- Post cardiac surgery 6 (28.6) Other 1 (4.8) Type of pacemaker (single) 35 (44.3) 9 (42.9) 0.906 New-onset heart failure at one year 0 (0.0) 5/13 (38.5) <0.001 Death at one year 5/77 (5.7) 2/12 (16.7) 0.223 Values are presented as numbers and percentages (%). IQR: interquartile range, CHB: complete heart block, AVB: atrioventricular block, AF: atrial fibrillation, TAVI: transcatheter aortic valve implantation
- Table 3
- Characteristics of patients with atrioventricular block (young idiopathic vs. old idiopathic).
Variables Young patients (n=21) Older patients (n=58) P-values Age (years), median (IQR) 56 (53-58) 75 (67-79) <0.001 Male gender 8 (38.1) 29 (50.0) 0.349 Hypertension 15 (71.4) 51 (87.9) 0.081 Diabetes mellitus 13 (61.9) 48 (82.5) 0.056 Dyslipidemia 4 (19.1) 25 (43.1) 0.05 Any comorbidity (hypertension, diabetes mellitus, or dyslipidemia) 17 (80.1) 56 (96.5) 0.022 Diagnosis CHB 11 (52.4) 41 (70.7) 0.473 2nd degree AVB 7 (33.3) 12 (20.7) AF with slow ventricular response 2 (9.5) 4 (6.9) Unknown 1 (4.8) 1 (1.7) Investigated for cardiac sarcoidosis 5 (23.8) 0 (0.0) 0.001 Type of pacemaker (single) 3 (14.3) 32 (55.2) 0.001 New-onset heart failure at one year -- -- -- Death at one year 0 (0.0) 5/56 (8.9) 0.05 Values are presented as numbers and percentages (%).
IQR: interquartile range, CHB: complete heart block, AVB: atrioventricular block, AF: atrial fibrillation